| 产品描述: | PF-06649298 is a sodium-coupled citrate transporter (NaCT or SLC13A5) inhibitor. PF-06649298 specifically interacts with NaCT with an IC50 value of 16.2 μM to inhibits the transport of citrate in human hepatocytes. PF-06649298 can be used for the research of regulating glucose metabolism and lipid metabolism. |
| 体内研究: |
PF-06649298 (0-100 μM; 30 min) inhibits citrate uptaken in cells. |
| 参考文献: |
1. Huard K, et al. Optimization of a Dicarboxylic Series for in Vivo Inhibition of Citrate Transport by the Solute Carrier 13 (SLC13) Family. J Med Chem. 2016 Feb 11;59(3):1165-75. 2. Huard K, et al. Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5). Sci Rep. 2015 Dec 1;5:17391. |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.397 ml |
16.987 ml |
33.974 ml |
| 5 mM |
0.679 ml |
3.397 ml |
6.795 ml |
| 10 mM |
0.34 ml |
1.699 ml |
3.397 ml |
| 50 mM |
0.068 ml |
0.34 ml |
0.679 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |